Overview

Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline

Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
This study investigates the add-on effect of oral minocycline in subjects treated with daily injection of Copaxone. Copaxone and minocycline are thought to have differential modes of actions that may complement each other in treating MS symptoms.
Phase:
Phase 2
Details
Lead Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Teva Pharmaceutical Industries
Treatments:
(T,G)-A-L
Glatiramer Acetate
Minocycline